HCN, MIMS release drug database updates
The update, which is current from April 1, includes a fully rebuilt MDref drug database, full consumer medicines information, product information, updated NPS Radar data and Medical Director content such as letter writer templates and post prescribing prompts.
Last week, HCN reminded users of Medical Director 2 that they will no longer be able to prescribe from May and must upgrade to MD3.
The April MDref update includes new drug monographs for Acirca (tadalafil) for pulmonary arterial hypertension and Fampyra (fampridine), to help improve walking ability in patients with multiple sclerosis.
MIMS has also released its April monthly medicines update, which includes new product information on Eviplera (tenofovir disoproxil fumarate, emtricitabine and rilpivirine), a combination nucleotide and a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection.
It also includes information on a new presentation of the Humulin NPH KwikPen insulin injection as a 3mL multiple dose, disposable pen device containing 100 units/mL in packs of fives.
Posted in Australian eHealth